Showing results (51-60 of 284) with videos related to
Sort By:
Pageof 29
Neurochemistry International|May 15, 2012
Botulinum toxin's axonal transport from periphery to the spinal cordIvica Matak, Peter Riederer, Zdravko LackovićJournal of Neural Transmission (Vienna, Austria : 1996)|March 17, 2017
Simultaneous determination of MAO-A and -B activity following first time intake of an irreversible MAO-B inhibitor in patients with Parkinson's diseaseThomas Müller, Peter Riederer, Edna GrünblattExpert Review of Clinical Pharmacology|February 2, 2023
Aminoadamantanes: from treatment of Parkinson's and Alzheimer's disease to symptom amelioration of long COVID-19 syndrome?Thomas Müller, Peter Riederer, Wilfried KuhnJournal of Neural Transmission (Vienna, Austria : 1996)|June 18, 2010
The link between iron, metabolic syndrome, and Alzheimer's diseaseEdna Grünblatt, Jasmin Bartl, Peter RiedererNeurotoxicology|December 31, 2003
Monoamine oxidase-B inhibition in Alzheimer's diseasePeter Riederer, Walter Danielczyk, Edna GrünblattThe World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 7, 2016
A proposal for a psychopharmacology-pharmacotherapy catalogue of learning objectives and a curriculum in EuropePierre Baumann, Marie Spies, Hans-Jürgen Möller, et al.Journal of Psychiatric Research|October 27, 2004
Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controlsMichael Soyka, Catja Winter, Sabine Kagerer, et al.The Journal of Clinical Psychiatry|February 11, 2009
The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patientsAlexander Brunnauer, Gerd Laux, Irmgard David, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 25, 2015
Editorial: Siegfried Hoyer's concept of Alzheimer pathophysiologyLutz Frölich, Walter E Müller, Peter RiedererCells|April 30, 2021
Perspective: Treatment for Disease Modification in Chronic NeurodegenerationThomas Müller, Bernhard Klaus Mueller, Peter RiedererPageof 29